250 related articles for article (PubMed ID: 1287032)
1. Targeted kill: from umbrellas to monoclonal antibodies.
Byers VS; Baldwin RW
J Clin Immunol; 1992 Nov; 12(6):391-405. PubMed ID: 1287032
[No Abstract] [Full Text] [Related]
2. Systemic immunotoxin therapy of cancer: advances and prospects.
Wawrzynczak EJ
Br J Cancer; 1991 Oct; 64(4):624-30. PubMed ID: 1911210
[No Abstract] [Full Text] [Related]
3. Manipulation of the immune response by monoclonal antibodies in auto-immune pathology.
Benoit P; Boucheix C
Curr Eye Res; 1990; 9 Suppl():201-5. PubMed ID: 2200645
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of autoimmune disease.
Cooke A; Wraith DC
Curr Opin Immunol; 1993 Dec; 5(6):925-33. PubMed ID: 8297526
[TBL] [Abstract][Full Text] [Related]
5. Rationale for clinical use of immunotoxins in cancer and autoimmune disease.
Byers VS; Baldwin RW
Semin Cell Biol; 1991 Feb; 2(1):59-70. PubMed ID: 1954344
[TBL] [Abstract][Full Text] [Related]
6. [Basic concept and clinical application of monoclonal antibody].
Nihon Rinsho; 1990 Aug; 48 Suppl():938-1124. PubMed ID: 2232229
[No Abstract] [Full Text] [Related]
7. Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS.
Vitetta ES
J Clin Immunol; 1990 Nov; 10(6 Suppl):15S-18S. PubMed ID: 2081785
[TBL] [Abstract][Full Text] [Related]
8. -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?
Ballow M
J Allergy Clin Immunol; 2005 Oct; 116(4):738-43. PubMed ID: 16210044
[No Abstract] [Full Text] [Related]
9. [Cancer therapy by using bispecific antibody].
Azuma A; Niitani H; Okumura K
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1535-42. PubMed ID: 1872618
[TBL] [Abstract][Full Text] [Related]
10. T cell targeted immunotherapy for autoimmune disease.
Lee E; Sinha AA
Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
Strom TB; Kelley VR; Murphy JR; Nichols J; Woodworth TG
Adv Nephrol Necker Hosp; 1994; 23():347-56. PubMed ID: 8154364
[No Abstract] [Full Text] [Related]
12. Serotherapy of cancer.
Harris DT; Mastrangelo MJ
Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
[No Abstract] [Full Text] [Related]
13. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy].
Renner C; Pfreundschuh M
Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887
[No Abstract] [Full Text] [Related]
14. Anti-class II antibody treatment in autoimmune diseases.
Boitard C
Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393
[No Abstract] [Full Text] [Related]
15. Anti-CD3 antibodies.
Chatenoud L; Bach JF
Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
[No Abstract] [Full Text] [Related]
16. Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
Kuhn C; Weiner HL
Immunotherapy; 2016 Jul; 8(8):889-906. PubMed ID: 27161438
[TBL] [Abstract][Full Text] [Related]
17. Therapy of rat autoimmune disease by a monoclonal antibody specific for T lymphoblasts.
Schluesener H; Brunner C; Vass K; Lassmann H
J Immunol; 1986 Dec; 137(12):3814-20. PubMed ID: 3491149
[TBL] [Abstract][Full Text] [Related]
18. Immunotoxins: magic bullets or misguided missiles?
Vitetta ES; Thorpe PE; Uhr JW
Immunol Today; 1993 Jun; 14(6):252-9. PubMed ID: 8397766
[TBL] [Abstract][Full Text] [Related]
19. Immunotoxins: magic bullets or misguided missiles?
Vitetta ES; Thorpe PE; Uhr JW
Trends Pharmacol Sci; 1993 May; 14(5):148-54. PubMed ID: 8212309
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody drug immunoconjugates for targeted treatment of cancer.
Trail PA; King HD; Dubowchik GM
Cancer Immunol Immunother; 2003 May; 52(5):328-37. PubMed ID: 12700948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
